Platelets are central mediators of thrombosis and hemostasis. At the site of vascular injury, platelet accumulation (i.e. adhesion and aggregation) constitutes the first wave of hemostasis. Blood coagulation, initiated by the coagulation cascades, is the second wave of thrombin generation and enhance phosphatidylserine exposure, can markedly potentiate cell-based thrombin generation and enhance blood coagulation. Recently, deposition of plasma fibronectin and other proteins onto the injured vessel wall has been identified as a new “protein wave of hemostasis” that occurs prior to platelet accumulation (i.e. the classical first wave of hemostasis). These three waves of hemostasis, in the event of atherosclerotic plaque rupture, may turn pathogenic, and cause uncontrolled vessel occlusion and thrombotic disorders (e.g. heart attack and stroke). Current anti-platelet therapies have significantly reduced cardiovascular mortality, however, on-treatment thrombotic events, thrombocytopenia, and bleeding complications are still major concerns that continue to motivate innovation and drive therapeutic advances. Emerging evidence has brought platelet adhesion molecules back into the spotlight as targets for the development of novel anti-thrombotic agents. These potential antiplatelet targets mainly include the platelet receptors glycoprotein (GP) Ib-IX-V complex, β3 integrins (αIIb subunit and PSI domain of β3 subunit) and GPVI. Numerous efforts have been made aiming to balance the efficacy of inhibiting thrombosis without compromising hemostasis. This mini-review will update the mechanisms of thrombosis and the current state of antiplatelet therapies, and will focus on platelet adhesion molecules and the novel anti-thrombotic therapies that target them.

No abstract

No abstract

Self-healing is a natural phenomenon whereby living organisms respond to damage. Recently, considerable research efforts have been invested in self-healing cementitious materials that are capable of restoring structural integrity and mechanical properties after being damaged. Inspired by nature, a variety of creative approaches are explored here based on the intrinsic or extrinsic healing mechanism. Research on new intrinsic self-healing cementitious materials with biomimetic features is on the forefront of material science, which provides a promising way to construct resilient and sustainable concrete infrastructures. Here, the current advances in the development of the intrinsic healing cementitious materials are described, and a new definition of intrinsic self-healing discussed. The methods to assess the efficiency of different healing mechanisms are briefly summarized. The critical insights are emphasized to guide the future research on the development of new self-healing cementitious materials.

No abstract

No abstract

No abstract

No abstract